Congfen Li
发表论文 58 篇 · 总被引 2263 次 · h-index 12
代表论文
- Data from HGF as a Circulating Biomarker of Onartuzumab Treatment in Patients with Advanced Solid Tumors (2023)
- Supplementary Figure 1 from HGF as a Circulating Biomarker of Onartuzumab Treatment in Patients with Advanced Solid Tumors (2023)
- Data from HGF as a Circulating Biomarker of Onartuzumab Treatment in Patients with Advanced Solid Tumors (2023)
- Supplementary Figure 2 from HGF as a Circulating Biomarker of Onartuzumab Treatment in Patients with Advanced Solid Tumors (2023)
- Supplementary Figure 1 from HGF as a Circulating Biomarker of Onartuzumab Treatment in Patients with Advanced Solid Tumors (2023)
- Supplementary Figure 2 from HGF as a Circulating Biomarker of Onartuzumab Treatment in Patients with Advanced Solid Tumors (2023)